Woori Bio Co., Ltd. (082850) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Woori Bio Co., Ltd. (082850:KRX), powered by AI.

Current Price
₩1,403
P/E Ratio
-7.3
Market Cap
68.0B
Sector
Common Stock
What is the Woori Bio Co., Ltd. stock price forecast?

Woori Bio Co., Ltd. is currently trading at ₩1,403. View real-time AI analysis on Alpha Lenz.

What is Woori Bio Co., Ltd. insider trading activity?

View the latest insider trading data for Woori Bio Co., Ltd. on Alpha Lenz.

What is Woori Bio Co., Ltd.'s P/E ratio?

Woori Bio Co., Ltd.'s P/E ratio is -7.3.

Woori Bio Co., Ltd.

KRX · 082850
₩1,403-16(-1.13%)Market closedKRX regular session 09:00–15:30 KST
Ask about Woori Bio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Woori Bio Co., Ltd. trades at a P/E of -7.3 (undervalued) with modest ROE of -4.5%.

Ask for details

Company Overview

Woori Bio Co., Ltd. is a notable player in the biotechnology sector, primarily focused on the development, manufacturing, and marketing of advanced healthcare solutions. The company specializes in creating cutting-edge bio-products and services designed to enhance human health and well-being. With a strong emphasis on research and innovation, Woori Bio is involved in various areas of biotechnology, including pharmaceuticals, biochemistry, and regenerative medicine. Woori Bio Co., Ltd. plays an integral role in advancing medical technology, impacting sectors such as pharmaceuticals, healthcare, and possibly agriculture, by contributing to the development of biosimilar drugs and other medical solutions. The company's efforts in biotechnology hold substantial significance, particularly in developing novel treatments and therapies, which are crucial in addressing a wide range of medical conditions and enhancing the quality of life. As the biotechnology industry continues to evolve, Woori Bio Co., Ltd. remains a key contributor by leveraging its expertise in scientific research and development, underscoring its importance to the global biotech landscape and the ongoing advancement of medical sciences.

CEO엄태욱, 윤지용
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩67,984,578,934Market Cap
₩1,043,962,208,890Revenue
48.46MShares Out
0Employees

Margins

9.11%Gross
2.95%EBITDA
0.09%Operating
-0.61%Pre-Tax
-0.97%Net

Valuation

-7.25P/E
0.33P/B
0.07EV/Sales
4.72EV/EBITDA
5.48P/FCF

Growth (CAGR)

-8.33%Rev 3Yr
-8.45%Rev 5Yr
-69.78%Op Inc 3Yr
-52.36%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.48%ROA
-4.50%ROE
-0.03%ROIC

Financial Health

₩107,031,094,730Cash & Cash Equivalents
₩393,542,600,920Net Debt
191.54%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Woori Bio Co., Ltd. (ticker: 082850) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $68.0B.

The current price is ₩1,403 with a P/E ratio of -7.25x and P/B of 0.33x.

ROE is -4.50% and operating margin is 0.09%. Annual revenue is $1.0T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Woori Bio Co., Ltd. (082850) Stock Forecast 2026 ₩1,403 — Price, Financials & Analyst Targets | Alpha Lenz